Literature DB >> 29360280

Dialysis disequilibrium syndrome leading to sudden brain death in a chronic hemodialysis patient.

Tarun Dalia1, Ahmad M Tuffaha2.   

Abstract

Dialysis disequilibrium syndrome (DDS) is a rare central nervous system (CNS) disease which develops in patients receiving hemodialysis (HD). Although it has been reported in patients receiving chronic HD, DDS is more common during or immediately after the first HD treatment. The exact incidence of DDS is unknown. Death in DDS is an extremely rare phenomenon and to the best of our knowledge only 9 cases have been reported showing this association. We present a unique case of a 42-year-old female on chronic HD, and no prior history of CNS disease, who developed brain death in the setting of DDS 2 hours into the dialysis treatment. A literature review of all previously reported cases was performed.
© 2018 International Society for Hemodialysis.

Entities:  

Keywords:  Dialysis disequilibrium syndrome; brain death; missed hemodialysis

Mesh:

Year:  2018        PMID: 29360280     DOI: 10.1111/hdi.12635

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  3 in total

Review 1.  Dialysis disequilibrium syndrome (DDS) in pediatric patients on dialysis: systematic review and clinical practice recommendations.

Authors:  Rupesh Raina; Andrew Davenport; Bradley Warady; Prabhav Vasistha; Sidharth Kumar Sethi; Ronith Chakraborty; Prajit Khooblall; Nirav Agarwal; Manan Vij; Franz Schaefer; Kunal Malhotra; Madhukar Misra
Journal:  Pediatr Nephrol       Date:  2021-10-05       Impact factor: 3.714

2.  Dialysis Disequilibrium Syndrome in a Patient With Acute Kidney Injury on Chronic Kidney Disease.

Authors:  Hajime Sanada; Kaori Yamaguchi; Taito Miyake
Journal:  Cureus       Date:  2021-06-12

3.  Use of non-invasive intracranial pressure pulse waveform to monitor patients with End-Stage Renal Disease (ESRD).

Authors:  Cristiane Rickli; Lais Daiene Cosmoski; Fábio André Dos Santos; Gustavo Henrique Frigieri; Nicollas Nunes Rabelo; Adriana Menegat Schuinski; Sérgio Mascarenhas; José Carlos Rebuglio Vellosa
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.